SIVE. What’s Going On?

Gaetano · Gaetano · 29 августа 2026, 21:13 · ⏱ 3 мин чтения  | Читать в Substack ↗
Резюме
SIVE's post-earnings frustration is largely a function of the stock racing far ahead of an early-stage business, not proof the thesis is broken. The company is positioned in a potentially massive optical cycle but remains years away from meaningful commercial revenue, so valuation swings should be expected as the business tries to catch up to sentiment.
  • SIVE's latest earnings triggered frustration because financials still look early-stage even after the stock moved from the high single digits to triple digits.
  • The author acknowledges missing SIVE's run from high single digits to triple digits because valuing a company years from commercial inflection was too difficult.
  • The author holds a small SIVE position from the 30s with a multi-year timeframe and sees significant upside only if the company executes, while explicitly acknowledging 'plenty of execution risk.'
  • Investor views on SIVE are split: some see the next Lumentum, some call it a 'shitco,' and some see an early optical story with potential; the author aligns with the third view.
  • The article argues the commercialization timeline never accelerated 10X just because the stock did, and investors now want customer names, production orders, LTAs, and revenue to validate the price.
  • POET, AEVA, LWLG, ALMU, and SIVE are grouped as pre-inflection companies where the market assigns meaningful value to future commercial success, creating both enormous upside and enormous downside risk.
Время чтения 3 мин
Объём 3,285 симв.
Категория finance
Идеи
crux_capital_ Independent Photonics & AI Infrastructure Researcher
SIVE is an early-stage optical company entering a massive optical cycle; the author sees meaningful multi-year upside if the company executes, but acknowledges the commercial story is still early and
SIVE is an early-stage optical company entering a massive optical cycle; the author sees meaningful multi-year upside if the company executes, but acknowledges the commercial story is still early and uncertain, so the position is sized small.
crux_capital_ Independent Photonics & AI Infrastructure Researcher
The article explicitly references Lumentum as the success case SIVE could become ('could become the next Lumentum') and builds SIVE's bullish case around a 'massive optical cycle,' implying establishe
The article explicitly references Lumentum as the success case SIVE could become ('could become the next Lumentum') and builds SIVE's bullish case around a 'massive optical cycle,' implying established optical incumbent Lumentum is also a listed beneficiary of that cycle narrative. Risk: If the cycle is slower to commercialize than expected, LITE's valuation could also be vulnerable to the same sentiment-to-fundamentals gap described for SIVE.
crux_capital_ Independent Photonics & AI Infrastructure Researcher
The author groups POET with SIVE as a pre-inflection company where 'the market is assigning meaningful value to future commercial success that still has to happen,' creating enormous downside when exp
The author groups POET with SIVE as a pre-inflection company where 'the market is assigning meaningful value to future commercial success that still has to happen,' creating enormous downside when expectations run too far ahead of the actual business. Risk: No company-specific bearish claim is made; POET could rally on execution or sentiment, and this is a sector-wide risk warning rather than a specific short thesis.
crux_capital_ Independent Photonics & AI Infrastructure Researcher
The article names AEVA among pre-inflection companies whose valuations rely on future commercial success, warning that the market can produce enormous downside if expectations outpace the actual busin
The article names AEVA among pre-inflection companies whose valuations rely on future commercial success, warning that the market can produce enormous downside if expectations outpace the actual business or if scaling never succeeds. Risk: The warning is generic to the category; AEVA-specific execution or partnerships could change the setup positively.
crux_capital_ Independent Photonics & AI Infrastructure Researcher
LWLG is explicitly listed alongside SIVE as a pre-inflection name where current stock value reflects future commercial success that still has to happen, with the same risk of downside when expectation
LWLG is explicitly listed alongside SIVE as a pre-inflection name where current stock value reflects future commercial success that still has to happen, with the same risk of downside when expectations get too far ahead. Risk: This is not an assertion that LWLG is overvalued; material news on commercialization could reverse the negative watch.
crux_capital_ Independent Photonics & AI Infrastructure Researcher
ALMU is included in the article's list of pre-inflection companies where the market assigns meaningful value to unproven future commercial outcomes, implying similar vulnerability to an expectations/b
ALMU is included in the article's list of pre-inflection companies where the market assigns meaningful value to unproven future commercial outcomes, implying similar vulnerability to an expectations/business gap. Risk: The article provides no ALMU-specific analysis; any positive commercial milestone could invalidate the caution.
Ещё от Gaetano

This newsletter, published August 29, 2026, features crux_capital_ discussing SIVE, LITE, POET, AEVA, LWLG, ALMU. 6 trade ideas extracted by AI with direction and confidence scoring.

Speakers: crux_capital_  · Tickers: SIVE, LITE, POET, AEVA, LWLG, ALMU